文献速递临床试验与 GCP

迷你剖腹术与经直肠自然腔道标本取出在微创结直肠癌手术中的比较:随机对照试验研究方案(MINITR-NOSE试验,TCAR2514方案)

Mini-laparotomy versus transrectal natural orifice specimen extraction for minimally invasive colorectal cancer surgery: study protocol for a randomized controlled trial (MINITR-NOSE trial, TCAR2514 protocol).
PubMed 文献 · Trials · 2025-08-25

本研究为单中心随机对照试验,在长庚纪念医院林口院区纳入符合标准的结直肠癌患者,随机分配接受经直肠自然腔道标本取出(NOSE)或传统微创手术。主要结局为术后C反应蛋白水平,次要结局包括短期并发症、恢复、再入院和长期生存。

要点

  • 单中心随机对照试验比较NOSE与传统微创手术治疗结直肠癌。
  • 主要结局为术后C反应蛋白水平,次要结局包括并发症、恢复、再入院及长期生存。
  • 两组均接受改良加速康复外科(ERAS)方案常规围手术期护理。

核心结论

  • 本研究旨在确定NOSE方法是否通过减少炎症和并发症而优于传统微创手术,可能改善患者恢复和结局。
  • 若有效,NOSE可能为结直肠癌切除术提供创伤更小的替代方案,促进结直肠外科肿瘤学进展。

研究设计与样本

  • 单中心随机对照试验,在长庚纪念医院林口院区纳入符合特定入选标准的结直肠癌患者。
  • 患者随机分配接受NOSE或传统微创手术。

主要发现

  • 主要结局为术后C反应蛋白水平作为炎症标志物。
  • 次要结局评估短期并发症、恢复、再入院和长期生存。
  • 两组均接受改良加速康复外科(ERAS)方案的常规围手术期护理,术后疼痛和并发症被系统记录并分级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Minimally invasive surgery (MIS) has improved colorectal cancer (CRC) treatment by reducing recovery time, pain, and infection risk compared to traditional open surgery, though a mini laparotomy is still needed for specimen removal. Natural orifice specimen extraction (NOSE) offers a promising alternative by using natural body openings for extraction, potentially minimizing complications further, yet requires more evidence to confirm its safety and effectiveness over conventional methods. METHODS: This single-center randomized controlled trial at Linkou Chang-Gung Memorial Hospital includes CRC patients meeting specific eligibility criteria, randomly assigned to undergo either NOSE or conventional MIS. Primary outcomes focus on postoperative C-reactive protein (CRP) levels as a marker of inflammation, with secondary outcomes evaluating short-term complications, recovery, readmission, and long-term survival. Both groups will receive routine perioperative care following modified Enhanced Recovery After Surgery (ERAS) protocols, with postoperative pain and complications systematically recorded and graded. DISCUSSION: This study seeks to determine whether the NOSE approach offers advantages over conventional MIS by reducing inflammation and complications, potentially improving patient recovery and outcomes. If effective, NOSE may present a less invasive alternative for CRC resection, contributing to advancements in colorectal surgical oncology. TRIAL REGISTRATION: ClinicalTrials.gov NCT05740267. Registered on March 1, 2023.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Lo AL, Hsu YJ, Chern YJ, et al. Mini-laparotomy versus transrectal natural orifice specimen extraction for minimally invasive colorectal cancer surgery: study protocol for a randomized controlled trial (MINITR-NOSE trial, TCAR2514 protocol). Trials. 2025. PMID: 40855494. doi:10.1186/s13063-025-09039-7

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。